In a win for Big Pharma, the U.S. Supreme Court on Monday remanded a class of failure-to-warn tort claims against drug manufacturer Merck to the U.S. Court of Appeals for the Third Circuit for determination by judges, not juries.

The court was unanimous on the result in Merck Sharp & Dohme v. Albrecht, and Justice Stephen Breyer wrote the opinion for the court. He was joined in an unusual lineup by Justices Clarence Thomas, Ruth Bader Ginsburg, Sonia Sotomayor, Elena Kagan and Neil Gorsuch. Thomas filed a separate concurrence, as did Justice Samuel Alito Jr., joined by Chief Justice John Roberts Jr. and Justice Brett Kavanaugh. The Alito concurrence agreed with the result, but not the reasoning.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]